Recommended Treatment for Shingles
For herpes zoster (shingles), the recommended first-line treatment is valacyclovir 1 gram three times daily for 7 days, initiated at the earliest sign or symptom of herpes zoster and ideally within 48 hours of rash onset. 1, 2
Antiviral Medication Options
First-line Treatment:
- Valacyclovir 1 gram three times daily for 7 days 1, 2
- Most effective when started within 48 hours of rash onset
- Convenient dosing (3 times daily) improves compliance
- Accelerates resolution of the rash and associated pain
- Reduces duration of postherpetic neuralgia
Alternative Options:
Famciclovir 500 mg three times daily for 7 days 1, 3
- Similar efficacy to valacyclovir
- Also administered three times daily
Acyclovir 800 mg five times daily for 7 days 1
- Less convenient dosing schedule (5 times daily)
- May be preferred during pregnancy due to established safety profile
Treatment Algorithm
Initiate antiviral therapy immediately
- Start treatment within 72 hours of rash onset for optimal efficacy
- Recent evidence suggests benefit may still exist even when started after 72 hours 4
Monitor treatment response
- Lesions should begin to resolve within 7-10 days
- If no improvement after 7-10 days, consider acyclovir-resistant HSV 1
Pain management
Follow-up within 7 days to:
- Assess treatment response
- Monitor for complete resolution of lesions
- Evaluate for signs of dissemination or complications 1
Special Considerations
Ocular Involvement
- If herpetic vesicles appear on the external auditory meatus or if there's risk of ocular involvement:
- Start valacyclovir 1000 mg three times daily for 7 days
- Urgent ophthalmology referral is essential due to risk of complications including keratitis, corneal scarring, uveitis, and secondary glaucoma 1
Pregnancy
- Acyclovir 800 mg orally 5 times daily is the preferred treatment during pregnancy
- Should be started within 72 hours of rash onset
- Continue until all lesions have scabbed or completely healed (typically 7-10 days) 1
Immunocompromised Patients
- May require longer courses of antiviral therapy
- More vigilant monitoring for complications 1
Common Pitfalls and Caveats
Delayed treatment initiation
Inadequate dosing frequency
- Adherence to the recommended dosing schedule is crucial for efficacy
- Twice-daily dosing of valacyclovir (1.5g bid) may be considered to improve compliance 5
Failure to recognize treatment resistance
- Suspect acyclovir-resistant HSV if lesions don't begin to resolve within 7-10 days
- Treatment of choice for resistant cases is IV foscarnet 1
Overlooking ocular complications
- Always assess for potential eye involvement, especially with facial or cranial nerve distribution
- Prompt ophthalmology referral is necessary when ocular involvement is suspected 1
Undertreatment of pain
- Pain management is a critical component of shingles treatment
- Follow a stepwise approach based on pain severity 1
Comparative studies have demonstrated that valacyclovir is superior to acyclovir in resolving zoster-associated pain and postherpetic neuralgia, while maintaining a similar safety profile 4, 6. The improved bioavailability of valacyclovir allows for less frequent dosing compared to acyclovir, which can enhance patient compliance 4.